Drug interactions
Mitoxantrone + Tafamidis
Severity: Moderate
Mitoxantrone and Tafamidis: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Tafamidis inhibits BCRP in vitro, and mitoxantrone is a BCRP substrate. Mitoxantrone exposure may therefore rise, increasing bone marrow and cardiac toxicity.
What this interaction means in plain words
Mitoxantrone and Tafamidis can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Mitoxantrone belongs to Central Nervous System; Tafamidis belongs to Cardiovascular.
Why it happens
Inhibition of BCRP efflux by tafamidis reduces mitoxantrone clearance.
What to do
Monitor blood counts and cardiac function, and consider reducing the mitoxantrone dose if adverse effects emerge.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Mitoxantrone and Tafamidis, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Mitoxantrone
Other interactions of Tafamidis
- Apixaban + Tafamidis Moderate
- Atorvastatin + Tafamidis Moderate
- Methotrexate + Tafamidis Moderate
- Pitavastatin + Tafamidis Moderate
- Rivaroxaban + Tafamidis Moderate
- Rosuvastatin + Tafamidis Moderate
Frequently asked questions
Can I take Mitoxantrone with Tafamidis?
MediHelp rates the interaction as moderate. Mitoxantrone and Tafamidis can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Tafamidis inhibits BCRP in vitro, and mitoxantrone is a BCRP substrate. Mitoxantrone exposure may therefore rise, increasing bone marrow and cardiac toxicity.
How serious is the interaction between Mitoxantrone and Tafamidis?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood counts and cardiac function, and consider reducing the mitoxantrone dose if adverse effects emerge.
What other medicines interact with Mitoxantrone?
MediHelp also lists interactions of Mitoxantrone with, for example, Adenovirus types 4 and 7 live, Axicabtagene ciloleucel, Belatacept. The full list is on the Mitoxantrone page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
